# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Regulation 22: Amendment of Schedule 5 (review upon oral representations)


(1) Schedule 5 is amended as follows.
(2) In paragraph 1(2)(e), 3(11)(b) and 5(2)(d) after—
(a) “UK marketing authorisation,” in each place it appears, insert “parallel import licence,”; and
(b) “an authorisation,” or “the authorisation,” in each place it appears, insert “licence,”.
(3) In paragraph 3 omit sub-paragraph (11)(b)(iii).
(4) In paragraph 5 omit sub-paragraph (2)(c).

---
Source: https://www.legislation.gov.uk/ukdsi/2019/9780111179185/regulation/22 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2019/regulation-22
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.